Редактирование: Aging genes 10-29 (раздел)

==BRAF==

* {{medline-title
|title=Conditional reprograming culture conditions facilitate growth of lower grade glioma models.
|date=01.12.2020
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/33258947
|full-text-url=https://sci-hub.do/10.1093/neuonc/noaa263
}}
* {{medline-title
|title=Active notch protects MAPK activated melanoma cell lines from MEK inhibitor cobimetinib.
|date=14.11.2020
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/33202284
|full-text-url=https://sci-hub.do/10.1016/j.biopha.2020.111006
}}
* {{medline-title
|title=Mitochondrial metabolic reprograming via [[BRAF]] inhibition ameliorates senescence.
|date=15.10.2019
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/31421186
|full-text-url=https://sci-hub.do/10.1016/j.exger.2019.110691
}}
* {{medline-title
|title=Deciphering the genotype and phenotype of hairy cell leukemia: clues for diagnosis and treatment.
|date=08.2019
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/31282776
|full-text-url=https://sci-hub.do/10.1080/1744666X.2019.1641405
}}
* {{medline-title
|title=A clinical trial of somatic and germline analyses for healthy longevity in a postoperative cancer patient.
|date=09.2019
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30843125
|full-text-url=https://sci-hub.do/10.1007/s00595-019-01789-7
}}
* {{medline-title
|title=Aging-like Spontaneous Epigenetic Silencing Facilitates Wnt Activation, Stemness, and Braf -Induced Tumorigenesis.
|date=11.02.2019
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30753828
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636642
}}
* {{medline-title
|title=Acquired resistance to [[BRAF]]i reverses senescence-like phenotype in mutant [[BRAF]] melanoma.
|date=07.08.2018
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30159130
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112757
}}
* {{medline-title
|title=Cancer modeling by Transgene Electroporation in Adult Zebrafish (TEAZ).
|date=27.09.2018
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30061297
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177007
}}
* {{medline-title
|title=Menopause and adipose tissue: miR-19a-3p is sensitive to hormonal replacement.
|date=05.01.2018
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/29416771
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788639
}}
* {{medline-title
|title=Impact of Age on Outcomes with Immunotherapy for Patients with Melanoma.
|date=08.2017
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/28476944
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553960
}}
* {{medline-title
|title=Establishment and application of a novel patient-derived KIAA1549:[[BRAF]]-driven pediatric pilocytic astrocytoma model for preclinical drug testing.
|date=14.02.2017
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/28002790
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355278
}}
* {{medline-title
|title=Detection of Reactive Oxygen Species in Cells Undergoing Oncogene-Induced Senescence.
|date=2017
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/27812875
|full-text-url=https://sci-hub.do/10.1007/978-1-4939-6670-7_13
}}
* {{medline-title
|title=GBM-associated mutations and altered protein expression are more common in young patients.
|date=25.10.2016
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/27579614
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342491
}}
* {{medline-title
|title=What makes oncogenes mutually exclusive?
|date=03.07.2017
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/27416373
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584735
}}
* {{medline-title
|title=Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression.
|date=05.04.2016
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/27052162
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826807
}}
* {{medline-title
|title=Combination with γ-secretase inhibitor prolongs treatment efficacy of [[BRAF]] inhibitor in [[BRAF]]-mutated melanoma cells.
|date=28.06.2016
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/27000992
|full-text-url=https://sci-hub.do/10.1016/j.canlet.2016.03.028
}}
* {{medline-title
|title=Parthenolide induces [[MITF]]-M downregulation and senescence in patient-derived [[MITF]]-M(high) melanoma cell populations.
|date=23.02.2016
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26824319
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891023
}}
* {{medline-title
|title=Encorafenib (LGX818), a potent [[BRAF]] inhibitor, induces senescence accompanied by autophagy in [[BRAF]]V600E melanoma cells.
|date=28.01.2016
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26586345
|full-text-url=https://sci-hub.do/10.1016/j.canlet.2015.11.015
}}
* {{medline-title
|title=Novel Therapies for Metastatic Melanoma: An Update on Their Use in Older Patients.
|date=10.2015
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26442859
|full-text-url=https://sci-hub.do/10.1007/s40266-015-0304-7
}}
* {{medline-title
|title=Expression of tumor-related Rac1b antagonizes B-Raf-induced senescence in colorectal cells.
|date=28.12.2015
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26341689
|full-text-url=https://sci-hub.do/10.1016/j.canlet.2015.08.027
}}
* {{medline-title
|title=Trametinib radiosensitises RAS- and [[BRAF]]-mutated melanoma by perturbing cell cycle and inducing senescence.
|date=11.2015
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26163092
|full-text-url=https://sci-hub.do/10.1016/j.radonc.2015.06.026
}}
* {{medline-title
|title=Near-genomewide RNAi screening for regulators of [[BRAF]](V600E) -induced senescence identifies [[RASEF]], a gene epigenetically silenced in melanoma.
|date=07.2014
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/24703243
|full-text-url=https://sci-hub.do/10.1111/pcmr.12248
}}
* {{medline-title
|title=Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis.
|date=11.2014
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/24471909
|full-text-url=https://sci-hub.do/10.3109/10428194.2014.887713
}}